Incidental Discovery of Pulmonary Emboli Via CT Scan: Impact of Detections on Patient Care and Resulting Complications
Launched by MEIR MEDICAL CENTER · Sep 29, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how often small blood clots in the lungs, known as pulmonary emboli, are found by chance when patients in the intensive care unit (ICU) have chest CT scans for other reasons, like checking for lung diseases. The researchers want to learn not only how common these findings are but also what happens next. For example, if doctors decide to start treatment with blood thinners (medications that help prevent blood clots), they want to see if this leads to any complications, such as bleeding.
To take part in this study, patients need to be admitted to the ICU between August 2020 and August 2024 and have had a chest CT scan during their stay. The trial is open to patients of all ages and genders, as long as they meet these criteria. If you or a loved one is eligible, the study will help gather important information that could improve care for future patients with similar conditions.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: All patients who were admitted to the ICU between 8/2020 and 8/2024 and underwent chest CT during ICU stay -
- • Exclusion Criteria: Missing information
- • -
About Meir Medical Center
Meir Medical Center is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a prominent sponsor of clinical studies, Meir Medical Center is committed to fostering collaboration among healthcare professionals, researchers, and patients to explore new therapies and treatment modalities. With a focus on ethical practices and patient safety, the center aims to contribute significantly to the scientific community while enhancing the quality of care provided to its diverse patient population. Through its robust infrastructure and multidisciplinary approach, Meir Medical Center stands at the forefront of medical innovation, driving progress in various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kfar Saba, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported